Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit.
Acute Kidney Injury
/ epidemiology
Adult
Black or African American
/ ethnology
Aged
Betacoronavirus
/ genetics
COVID-19
Case-Control Studies
Comorbidity
Coronavirus Infections
/ blood
Cough
/ etiology
Dyspnea
/ etiology
Female
Fever
/ etiology
Hospitalization
/ statistics & numerical data
Humans
Intensive Care Units
/ statistics & numerical data
Length of Stay
/ trends
Male
Michigan
/ epidemiology
Middle Aged
Obesity
/ epidemiology
Pandemics
Pneumonia, Viral
/ blood
Prevalence
Respiration, Artificial
/ adverse effects
Respiratory Insufficiency
/ epidemiology
Retrospective Studies
SARS-CoV-2
Journal
JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235
Informations de publication
Date de publication:
01 06 2020
01 06 2020
Historique:
entrez:
17
6
2020
pubmed:
17
6
2020
medline:
25
6
2020
Statut:
epublish
Résumé
In late December 2019, an outbreak caused by a novel severe acute respiratory syndrome coronavirus 2 emerged in Wuhan, China. Data on the clinical characteristics and outcomes of infected patients in urban communities in the US are limited. To describe the clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and to perform a comparative analysis of hospitalized and ambulatory patient populations. This study is a case series of 463 consecutive patients with COVID-19 evaluated at Henry Ford Health System in metropolitan Detroit, Michigan, from March 9 to March 27, 2020. Data analysis was performed from March to April 2020. Laboratory-confirmed severe acute respiratory syndrome coronavirus 2 infection. Demographic data, underlying comorbidities, clinical presentation, complications, treatment, and outcomes were collected. Of 463 patients with COVID-19 (mean [SD] age, 57.5 [16.8] years), 259 (55.9%) were female, and 334 (72.1%) were African American. Most patients (435 [94.0%]) had at least 1 comorbidity, including hypertension (295 patients [63.7%]), chronic kidney disease (182 patients [39.3%]), and diabetes (178 patients [38.4%]). Common symptoms at presentation were cough (347 patients [74.9%]), fever (315 patients [68.0%]), and dyspnea (282 patients [60.9%]). Three hundred fifty-five patients (76.7%) were hospitalized; 141 (39.7%) required intensive care unit management and 114 (80.8%) of those patients required invasive mechanical ventilation. Male sex (odds ratio [OR], 2.0; 95% CI, 1.3-3.2; P = .001), severe obesity (OR, 2.0; 95% CI, 1.4-3.6; P = .02), and chronic kidney disease (OR, 2.0; 95% CI, 1.3-3.3; P = .006) were independently associated with intensive care unit admission. Patients admitted to the intensive care unit had longer length of stay and higher incidence of respiratory failure and acute respiratory distress syndrome requiring invasive mechanical ventilation, acute kidney injury requiring dialysis, shock, and mortality (57 patients [40.4%] vs 15 patients [7.0%]) compared with patients in the general practice unit. Twenty-nine (11.2%) of those discharged from the hospital were readmitted and, overall, 20.0% died within 30 days. Male sex (OR, 1.8; 95% CI, 1.1-3.1; P = .03) and age older than 60 years (OR, 5.3; 95% CI, 2.9-9.7; P < .001) were significantly associated with mortality, whereas African American race was not (OR, 0.98; 95% CI, 0.54-1.8; P = .86). In this review of urban metropolitan patients with COVID-19, most were African American with a high prevalence of comorbid conditions and high rates of hospitalization, intensive care unit admission, complications, and mortality due to COVID-19.
Identifiants
pubmed: 32543702
pii: 2767216
doi: 10.1001/jamanetworkopen.2020.12270
pmc: PMC7298606
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2012270Références
Obesity (Silver Spring). 2020 Apr 9;:
pubmed: 32271993
JAMA. 2020 Apr 24;:
pubmed: 32329797
Ann Intern Med. 1985 Jul;103(1):147-51
pubmed: 4003973
Travel Med Infect Dis. 2020 Mar - Apr;34:101623
pubmed: 32179124
JAMA. 2020 Feb 24;:
pubmed: 32091533
JAMA. 2020 Apr 22;:
pubmed: 32320003
JAMA. 2012 Jun 20;307(23):2526-33
pubmed: 22797452
JAMA. 2020 Mar 19;:
pubmed: 32191259
J Community Health. 2014 Apr;39(2):301-9
pubmed: 23990337
MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):343-346
pubmed: 32214079
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):458-464
pubmed: 32298251
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
MMWR Surveill Summ. 2018 Mar 30;67(5):1-11
pubmed: 29596406
JAMA. 2020 Apr 6;:
pubmed: 32250385
JAMA. 2020 Feb 28;:
pubmed: 32108857
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264